10.1002/anie.201712167
Angewandte Chemie International Edition
COMMUNICATION
Although biosynthetic pathways of the amphidinols are not fully
elucidated, a 13C metabolite labeling pattern was reported by the
feeding experiment of 13C-enriched acetate (Figure 5b).16 The labeling
patterns are not symmetrical between the A- and B-ring moieties, and
the arrangement of the A- and B-rings is anti-parallel, head-to-tail to
tail-to-head (Figure 5c). Therefore, it is plausible that the two antipodal
tetrahydropyran moieties were constructed coincidentally in the
biosynthetic pathway, and it is not considered to be unnatural
phenomenon. It has been reported that enantiomeric natural products
can arise from a single or different species, and that both diastereomers
possessing enantiomeric partial structures can arise from a single
species.17,18 It is interesting to note that both enantiomers of the partial
The authors declare no conflict of interest.
Keywords: Amphidinol 3 • Natural Product• Structure
Elucidation • Organic Synthesis • Stereochemistry
[1]
[2]
a) M. Satake, M. Murata, T. Yasumoto, T. Fujita, H. Naoki, J. Am. Chem. Soc.
1991, 113, 9859. b) M. Murata, S. Matsuoka, N. Matsumori, G. K. Paul, K.
Tachibana, J. Am. Chem. Soc. 1999, 121, 870.
a) T. Houdai, S. Matsuoka, N. Morsy, N. Matsumori, M. Satake, M. Murata,
Tetrahedron 2005, 61, 2795. b) R. T. Swasono, R. Mouri, N. Morsy, N.
Matsumori, T. Oishi, M. Murata, Bioorg. Med. Chem. Lett. 2010, 20, 2215. c)
R. A. Espiritu, N. Matsumori, M. Tsuda, M. Murata, Biochemistry 2014, 53,
3287.
structures exist in
a
single molecule in the nonactines19 and
[3]
[4]
N. Matsumori, D. Kaneno, M. Murata, H. Nakamura, Tachibana, K. J. Org.
Chem. 1999, 64, 866.
oxasqualenoids.20 However, to the best of our knowledge, this is the
first example of two antipodal tetrahydropyran rings existing on a
single carbon chain in the family of amphidinols and related
compounds. It is also noteworthy that stereochemical revision of AM3
would afford significant contribution to elucidate the 3D structure and
mode of action of AM3.
a) Y. Meng, R. M. Van Wagoner, I. Misner, C. Tomas, J. L. C. Wright, J. Nat.
Prod. 2010, 73, 409. b) J. Kobayashi, T. Kubota, J. Nat. Prod. 2007, 70, 451.
c) K. Washida, T. Koyama, K. Yamada, M. Kita, D. Uemura, Tetrahedron Lett.
2006, 47, 2521. d) S.-J. Huang, C.-M. Kuo, Y.-C. Lin, Y.-M. Chen, C.-K. Lu,
Tetrahedron Lett. 2009, 50, 2512. e) T. Inuzuka, Y. Yamamoto, K. Yamada, D.
Uemura, Tetrahedron Lett. 2012, 53, 239. f) J. Peng, A. R. Place, W. Yoshida,
C. Anklin, M. T. Hamann, J. Am. Chem. Soc. 2010, 132, 3277. g) Waters, A.
L.; Oh, J.; Place, A. R.; Hamann, M. T. Angew. Chem., Int. Ed. 2015, 54,
15705.
[5]
a) T. Oishi, M. Kanemoto, R. Swasono, N. Matsumori, M. Murata, Org. Lett.
2008, 10, 5203. b) M. Kanemoto, M. Murata, T. Oishi, J. Org. Chem. 2009, 74,
8810. c) Y. Manabe, M. Ebine, N. Matsumori, M. Murata, T. Oishi, J. Nat.
Prod. 2012, 75, 2003. d) M. Ebine, M. Kanemoto, Y. Manabe, Y. Konno, K.
Sakai, N. Matsumori, M. Murata, T. Oishi, Org. Lett. 2013, 15, 2846. e) T.
Tsuruda, M. Ebine, A. Umeda, T. Oishi J. Org. Chem. 2015, 80, 859. f) M.
Ebine, Y. Takada, N. Yanai, T. Oishi, Chem. Lett. 2017, 46, 662.
I. Ohtani, T. Kusumi, Y. Kashman, H. Kakisawa, J. Am. Chem. Soc. 1991,
113, 4092.
[6]
[7]
[8]
For a review, see: C. Bensoussan, N. Rival, G. Hanquet, F. Colobert, S.
Reymond, J. Cossy, Nat. Prod. Rep. 2014, 31, 468.
a) C. Bensoussan, N. Rival, G. Hanquet, F. Colobert, S. Reymond, J. Cossy,
Tetrahedron 2013, 69, 7759. b) N. Rival, G. Hanquet, C. Bensoussan, S.
Reymond, J. Cossy, F. Colobert, Org. Biomol. Chem. 2013, 11, 6829. c) E. M.
Flamme, W. R. Roush, Org. Lett. 2005, 7, 1411. d) J. D. Hicks, E. M. Flamme,
W. R. Roush, Org. Lett. 2005, 7, 5509. e) J. D. Hicks, W. R. Roush, Org. Lett.
2008, 10, 681. f) J. de Vicente, J. R. Huckins, S. D. Rychnovsky, Angew.
Chem. Int. Ed. 2006, 45, 7258. g) J. R. Huckins, J. de Vicente, S. D.
Rychnovsky, Org. Lett. 2007, 9, 4757. h) L. A. Paquette, S.-K. Chang, Org.
Lett. 2005, 7, 3111. i) S.-K. Chang, L. A. Paquette, Synlett 2005, 2915. j) M.
W. Bedore, S.-K. Chang, L. A. Paquette, Org. Lett. 2007, 9, 513. k) M. T.
Crimmins, T. J. Martin, T. A. Martinot, Org. Lett. 2010, 12, 3890. l) A. Grisin,
P. A. Evans, Chem. Sci. 2015, 6, 6407. m) J. S. Yadav, Y. Gopalarao, D.
Chandrakanth, B. V. S. Reddy, Helv. Chim. Acta 2016, 99, 436.
Figure 5. (a) Revised structure of AM3. (b) 13C metabolite
labeling pattern of AM3. (c) Arrangement of the A- and B-rings of
AM3.
In conclusion, syntheses of the C31–C67 part (1a) of AM3 and the
diastereomer at C32–C36 and C38 (1b) were achieved to confirm the
absolute configuration of the natural product. By comparison of the
NMR data of 1a and 1b with those of AM3 in combination with the
degradation of the natural product, the absolute configuration of AM3
was revised to be 32S, 33R, 34S, 35S, 36S, and 38S. The present results
suggest that structures of AM3 congeners should also be corrected, and
investigations toward this end are currently in progress.
[9]
P. R. Blakemore, W. J. Cole, P. J. Kocienski, A. Morley, Synlett 1998, 26.
[10] M. A. Blanchette, W. Choy, J. T. Davis, A. P. Essenfeld, S. Masamune, W. R.
Roush, T. Sakai, Tetrahedron Lett. 1984, 25, 2183.
[11] D. L. Comins, A. Dehghani, Tetrahedron Lett. 1992, 33, 6299.
[12] See Supporting Information.
[13] The absolute configuration was determined by the modified Mosher method.
[14] A. R. Pereira, J. A. Cabezas, J. Org. Chem. 2005, 70, 2594.
[15] F. Gao, A. H. Hoveyda, J. Am. Chem. Soc. 2010, 132, 10961.
[16] T. Houdai, S. Matsuoka, M. Murata, M. Satake, S. Ota, Y. Oshima, L. L.
Rhodes, Tetrahedron 2001, 57, 5551.
Acknowledgements
This work was supported in part by JST ERATO Lipid Active
Structure, and JSPS KAKENHI Grant Numbers JP24750092,
JP15K17857, JP15K13645, and JP16H01159 in Middle Molecular
Strategy.
[17] J. M. Finefield, D. H. Sherman, M. Kreitman, R. M. Williams, Angew. Chem.,
Int. Ed. 2012, 51, 4802.
[18] A. Hoshino, H. Nakai, M. Morino, K. Nishikawa, T. Kodama, K. Nishikibe, Y.
Morimoto, Angew. Chem. Int. Ed. 2017, 56, 3064.
[19] W. C. Smith, L. Xiang, B. Shen, Antimicrob. Agents Chemother. 2000, 44,
1809.
Conflict of interest
[20] J. J. Fernández, M. L. Souto, M. Norte, Nat. Prod. Rep. 2000, 17, 235.
This article is protected by copyright. All rights reserved.